Institutional Shareholder Services
Provider of corporate governance and responsible investment solutions.
Based in MD
🤖
AI Overview
With $1.1M in lobbying spend across 20 quarterly filings, Institutional Shareholder Services is a significant lobbying presence. They deploy 11 individual lobbyists Their lobbying covers 6 issue areas. Active from 2021 to 2025.
$1.1M
Total Spend
5
Years Active
1
Firms Hired
11
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $60K |
| 2022 | $255K |
| 2023 | $300K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues, Insurance, Financial, Budget/Appropriations and 1 more
- •Issues related to regulation of proxy advisory firms and issues related to corporate governance; Issues related to retirement funds managed under ERISA.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Follow the Money
Tracking lobbying dollars through the financial system.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Amalgamated Transit Union
$1.9M total spend
National Tooling and Machining Association
$1.1M total spend
International Association of Heat and Frost Insulators and Allied Workers
$720K total spend
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
State Fund Congressional Action Group (Sfcag)
$2.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.